Omega Healthcare Investors Stock Forecast, Price & News

Omega Healthcare Investors' stock was trading at $31.44 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, OHI shares have increased by 14.4% and is now trading at $35.97.
View which stocks have been most impacted by COVID-19.

12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Omega Healthcare Investors in the last twelve months. There are currently 4 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Omega Healthcare Investors stock.
View analyst ratings for Omega Healthcare Investors or view MarketBeat's top 5 stock picks.

Wall Street analysts have given Omega Healthcare Investors a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Omega Healthcare Investors wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

3 employees have rated Omega Healthcare Investors CEO C. Taylor Pickett on Glassdoor.com. C. Taylor Pickett has an approval rating of 56% among Omega Healthcare Investors' employees. This puts C. Taylor Pickett in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Omega Healthcare Investors is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Omega Healthcare Investors.

Omega Healthcare Investors, Inc. (NYSE:OHI) posted its quarterly earnings data on Thursday, October, 29th. The real estate investment trust reported ($0.40) earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.78 by $1.18. The real estate investment trust earned $81.21 million during the quarter, compared to the consensus estimate of $214.56 million. Omega Healthcare Investors had a trailing twelve-month return on equity of 3.78% and a net margin of 17.99%. The company's revenue for the quarter was down 59.2% on a year-over-year basis. During the same period last year, the company earned $0.76 earnings per share.
View Omega Healthcare Investors' earnings history.

Omega Healthcare Investors announced a quarterly dividend on Thursday, October 22nd. Investors of record on Monday, November 2nd will be given a dividend of $0.67 per share on Monday, November 16th. This represents a $2.68 annualized dividend and a yield of 7.45%. The ex-dividend date is Friday, October 30th.
View Omega Healthcare Investors' dividend history.

Omega Healthcare Investors pays an annual dividend of $2.68 per share and currently has a dividend yield of 7.45%. OHI has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of Omega Healthcare Investors is 87.30%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, Omega Healthcare Investors will have a dividend payout ratio of 84.54% in the coming year. This indicates that Omega Healthcare Investors may not be able to sustain their current dividend.
View Omega Healthcare Investors' dividend history.

12 brokers have issued twelve-month price objectives for Omega Healthcare Investors' shares. Their forecasts range from $30.00 to $43.00. On average, they anticipate Omega Healthcare Investors' stock price to reach $36.21 in the next twelve months. This suggests a possible upside of 0.7% from the stock's current price.
View analysts' price targets for Omega Healthcare Investors or view Wall Street analyst' top-rated stocks.

Omega Healthcare Investors saw a increase in short interest in December. As of December 31st, there was short interest totaling 9,760,000 shares, an increase of 18.9% from the December 15th total of 8,210,000 shares. Based on an average trading volume of 1,590,000 shares, the days-to-cover ratio is currently 6.1 days.
View Omega Healthcare Investors' Short Interest.

Some companies that are related to Omega Healthcare Investors include American Tower (AMT), Public Storage (PSA), Welltower (WELL), Weyerhaeuser (WY), Ventas (VTR), Extra Space Storage (EXR), HCP (HCP), Medical Properties Trust (MPW), CubeSmart (CUBE), Life Storage (LSI), Rayonier (RYN), Healthcare Realty Trust (HR), Ryman Hospitality Properties (RHP), Sabra Health Care REIT (SBRA) and PotlatchDeltic (PCH).
View all of OHI's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Omega Healthcare Investors investors own include AT&T (T), Enterprise Products Partners (EPD), Verizon Communications (VZ), Energy Transfer (ET), Realty Income (O), Cisco Systems (CSCO), AbbVie (ABBV), Annaly Capital Management (NLY), New Residential Investment (NRZ) and Pfizer (PFE).

Omega Healthcare Investors trades on the New York Stock Exchange (NYSE) under the ticker symbol "OHI."

Omega Healthcare Investors' stock is owned by many different retail and institutional investors. Top institutional investors include Edmp Inc. (0.07%), Insight Folios Inc (0.05%), State of Alaska Department of Revenue (0.04%), Baugh & Associates LLC (0.03%), DNB Asset Management AS (0.02%) and Redpoint Investment Management Pty Ltd (0.01%). Company insiders that own Omega Healthcare Investors stock include Ben W Perks, Burke W Whitman, C Taylor Pickett, Craig R Callen, Daniel J Booth, Michael Ritz, Robert O Stephenson and Steven J Insoft.
View institutional ownership trends for Omega Healthcare Investors.

OHI stock was sold by a variety of institutional investors in the last quarter, including Pacer Advisors Inc., DNB Asset Management AS, Avantax Advisory Services Inc., First Midwest Bank Trust Division, Park Avenue Securities LLC, Edmp Inc., We Are One Seven LLC, and State of Alaska Department of Revenue. Company insiders that have sold Omega Healthcare Investors company stock in the last year include C Taylor Pickett, Daniel J Booth, Michael Ritz, and Robert O Stephenson.
View insider buying and selling activity for Omega Healthcare Investors or view top insider-selling stocks.

OHI stock was bought by a variety of institutional investors in the last quarter, including Brookstone Capital Management, Sound Income Strategies LLC, Insight Folios Inc, MONECO Advisors LLC, Bennicas & Associates Inc., Redpoint Investment Management Pty Ltd, IFM Investors Pty Ltd, and International Assets Investment Management LLC. Company insiders that have bought Omega Healthcare Investors stock in the last two years include Burke W Whitman, and Craig R Callen.
View insider buying and selling activity for Omega Healthcare Investors or or view top insider-buying stocks.

Shares of OHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of OHI stock can currently be purchased for approximately $35.97.

Omega Healthcare Investors has a market capitalization of $8.17 billion and generates $928.83 million in revenue each year. The real estate investment trust earns $341.12 million in net income (profit) each year or $3.07 on an earnings per share basis. Omega Healthcare Investors employs 49 workers across the globe.

The official website for Omega Healthcare Investors is www.omegahealthcare.com.

Omega Healthcare Investors' mailing address is 303 International Circle Suite 200, HUNT VALLEY MD, 21030. The real estate investment trust can be reached via phone at 410-427-1700 or via email at [email protected]